From Casetext: Smarter Legal Research

Ramirez v. Drug Enf't Agency

United States District Court, District of Columbia
Nov 20, 2024
Civil Action 1:24-cv-01731 (UNA) (D.D.C. Nov. 20, 2024)

Opinion

Civil Action 1:24-cv-01731 (UNA)

11-20-2024

DOMINGO RAMIREZ, Plaintiff, v. DRUG ENFORCEMENT AGENCY, Defendant.


MEMORANDUM OPINION

ANA C. REYES, United States District Judge

This matter is before the Court on its initial review of plaintiff's pro se Complaint (“Compl.”), ECF No. 1, and application for leave to proceed in forma pauperis, ECF No. 2. The Court grants the in forma pauperis application and, for the reasons discussed below, dismisses this case without prejudice.

“A complaint must contain sufficient factual matter, accepted as true, to ‘state a claim to relief that is plausible on its face.'” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007)). A complaint that lacks “an arguable basis either in law or in fact” is frivolous, Neitzke v. Williams, 490 U.S. 319, 325 (1989), and a “complaint plainly abusive of the judicial process is properly typed malicious,” Crisafi v. Holland, 655 F.2d 1305, 1309 (D.C. Cir. 1981).

Here, Plaintiff sues the Drug Enforcement Administration (“DEA”), Corpus Christi Headquarters. See Compl. at 1; Compl. Exhibit 1, ECF No. 1-1 (S.D. Tex. Compl.) (“SD Compl.”), at 1. The Complaint is not a model in clarity, failing to comply procedurally with Federal Rules 8(a) and 10(a)-(b), and D.C. Local Civil Rule 5.1(c)(1), (d), (e), and (g). See generally Compl.; S.D. Compl.

The allegations themselves fare no better. Plaintiff introduces the Complaint by alleging that the United States District Court for the Southern District of Texas conspired with the DEA to bring charges against him, and he demands that his case be tried in another federal district court, a state court, or a military court, instead of the Southern District. See Compl. at 2. Next, he attaches a complaint either filed, or intended to be filed, in the Southern District of Texas, which appears to contain the crux of his allegations. See generally S.D. Compl. Therein, he alleges that, since May 2023, the DEA has “implanted [him] with a device/gadget called Bold FMRI,” and while under its control, it has caused him myriad psychological, physical, and social problems. See Id. at 2-4. He contends that the device “controls the nervous system and eyes and thoughts which can [then] be reconstructed” by the DEA. See S.D. Compl. Exhibit 1 (“SD Compl. Ex. 1”), ECF No. 12, at 2. He further alleges that, by use of this “gadget,” the DEA was able to “hack into” his social media accounts, bank accounts, and medical records. See S.D. Compl. at 2-3. The remainder of the allegations are even more paranoid and digressive. See, e.g., id. at 2; S.D. Compl. Ex. 1 at 2.

The Court cannot exercise subject-matter jurisdiction over a frivolous complaint. Hagans v. Lavine, 415 U.S. 528, 536-37 (1974) (“Over the years, this Court has repeatedly held that the federal courts are without power to entertain claims otherwise within their jurisdiction if they are ‘so attenuated and unsubstantial as to be absolutely devoid of merit.'”) (quoting Newburyport Water Co. v. Newburyport, 193 U.S. 561, 579 (1904)); Tooley v. Napolitano, 586 F.3d 1006, 1010 (D.C. Cir. 2009) (examining cases dismissed “for patent insubstantiality,” including where the plaintiff allegedly “was subjected to a campaign of surveillance and harassment deriving from uncertain origins”). A court may dismiss a complaint as frivolous “when the facts alleged rise to the level of the irrational or the wholly incredible,” Denton v. Hernandez, 504 U.S. 25, 33 (1992), or “postulat[e] events and circumstances of a wholly fanciful kind,” Crisafi, 655 F.2d at 1307-08. The instant Complaint satisfies this standard. In addition to failing to state a claim for relief, the Complaint is deemed frivolous on its face. See 28 U.S.C. § 1915(e)(2)(B)(i).

Finally, insofar as Plaintiff attempts to somehow unliterally transfer this case from another District, see Compl. at 2; S.D. Compl. at 1; S.D. Compl. Ex. 1 at 1, he bears no authority to do so. See generally 28 U.S.C. §§ 1404, 1406 (providing courts, not litigants, with the power to transfer a case). Moreover, this Court lacks subject-matter jurisdiction to review the decisions of other federal courts. See In re Marin, 956 F.2d 339 (D.C. Cir. 1992); Panko v. Rodak, 606 F.2d 168, 171 n.6 (7th Cir. 1979) (finding it “axiomatic” that a federal court may order judges or officers of another federal court “to take an action”), cert. denied, 444 U.S. 1081 (1980); United States v. Choi, 818 F.Supp.2d 79, 85 (D.D.C. 2011) (stating that federal district courts “generally lack[] appellate jurisdiction over other judicial bodies, and cannot exercise appellate mandamus over other courts”) (citing Lewis v. Green, 629 F.Supp. 546, 553 (D.D.C. 1986)); Fleming v. United States, 847 F.Supp. 170, 172 (D.D.C. 1994) (applying District of Columbia Court of Appeals v. Feldman, 460 U.S. 462, 482 (1983) and Rooker v. Fidelity Trust Co., 263 U.S. 413, 415, 416 (1923)), aff'd, No. 94-5079, 1994 WL 474995 (D.C. Cir. 1994).

For all these reasons, the Complaint, ECF No. 1, and this case, are dismissed without prejudice. Plaintiff's first motion for discovery, ECF No. 3, second motion for discovery, ECF No. 4, motion for order to release evidence, ECF No. 5, and motion for speedy trial, ECF No. 6, are all denied as moot. A separate Order accompanies this Memorandum Opinion.


Summaries of

Ramirez v. Drug Enf't Agency

United States District Court, District of Columbia
Nov 20, 2024
Civil Action 1:24-cv-01731 (UNA) (D.D.C. Nov. 20, 2024)
Case details for

Ramirez v. Drug Enf't Agency

Case Details

Full title:DOMINGO RAMIREZ, Plaintiff, v. DRUG ENFORCEMENT AGENCY, Defendant.

Court:United States District Court, District of Columbia

Date published: Nov 20, 2024

Citations

Civil Action 1:24-cv-01731 (UNA) (D.D.C. Nov. 20, 2024)